Blocacid - Blocacid, a competitive histamine H2-receptor antagonist, is used to treat gastrointestinal disorders such as gastric or duodenal ulcer, gastroesophageal reflux disease, and pathological hypersecretory conditions. Blocacid inhibits many of the isoenzymes of the hepatic CYP450 enzyme system. Other actions of Blocacid include an increase in gastric bacterial flora such as nitrate-reducing organisms.
Indication: For the treatment of peptic ulcer disease (PUD) and gastroesophageal reflux disease (GERD).
Blocacid is a gastric medicine. It is used to treat conditions caused by excessive acidity in your stomach, such as stomach ulcers and reflux disease (also known as "heartburn", in which there is a backward flow of food or acid from your stomach into your mouth, leaving a sour or bitter taste). Blocacid can also be used to relieve stomach irritation and ulceration caused by certain painkillers such as non-steroidal anti-inflammatory drugs (NSAIDs). Blocacid treats these conditions by reducing the amount of acid your stomach makes.
Indications: peptic ulcer, zollinger-ellison syndrome
Benign gastric and duodenal ulceration, Gastro-oesophageal reflux disease, Zollinger-Ellison syndrome,Non-ulcer dyspepsia, Heartburn,Benign gastric and duodenal ulceration.
Blocacid is a histamine H2-receptor antagonist that inhibits stomach acid production, and it is commonly used in the treatment of peptic ulcer disease (PUD) and gastroesophageal reflux disease (GERD/GORD). It is commonly marketed by Johnson & Johnson/Merck under the trade names Pepcidine and Pepcid. Unlike cimetidine, the first H2 antagonist, Blocacid has no effect on the cytochrome P450 enzyme system, and does not appear to interact with other drugs.
Treatment of RA, osteoarthritis, ankylosing spondylitis, primary dysmenorrhea. Relief of acute &/or chronic pain w/ inflammation.
Indications: Duodenal or beign gastric ulcer, gastroesophageal reflux disease.